Jill Beierle, MS, is a Manager in Regulatory Affairs-CMC at Amgen, Inc., and on the advocacy and external engagement team. Jill has a wide range of experience ranging from early discovery proteomics, formulation, and quality including leading regulatory filings in early and late stage programs. Areas of high interest include collaboration in crossfunctional areas to identify new technologies to acquire information concerning scientific developments that can impact product development in design and data analysis for improved regulatory outcomes. Jill is active in organizations such as IQ. She holds a master's degree in regulatory science from the University of Southern California School of Pharmacy. Jill joined ISPE in 2021.